mPTP — Drug Target

All drugs that target mPTP — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Mitochondrial permeability transition pore inhibitor · mPTP inhibitor

Phase 2 pipeline (2)

• KL1333 · Abliva AB · Mitochondrial permeability transition pore inhibitor · Oncology
  KL1333 is a small molecule that targets the mitochondrial permeability transition pore (mPTP) to induce cell death in cancer cells.
• Apatone®B · IC-MedTech Corporation · mPTP inhibitor · Cardiovascular
  Apatone B is a small molecule that targets the mitochondrial permeability transition pore (mPTP) to prevent cell death.